findmyKOL

Kirsten Tillisch, MD

Enriched profile

Health Sciences Clinical Professor of Medicine; Chief, Integrative Medicine, VA Greater Los Angeles Healthcare System · UCLA

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyGastroenterologyFocusGastrointestinal motility and disorders+4
Active KOLfindmyKOL type: EliteLatest publication2020Online presenceNone verifiedPayments2025–2025NIH funding2006–2015

Kirsten Tillisch is Health Sciences Clinical Professor of Medicine; Chief, Integrative Medicine, VA Greater Los Angeles Healthcare System at UCLA. OpenAlex indexes 221 publications with 11,846 citations (h-index 54); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.

Data verified 11 Oct 2026

Overview

Updated 14 Oct 2026

Kirsten Tillisch, MD, is Health Sciences Clinical Professor of Medicine at UCLA. The public record shows 221 publications with 11,846 citations (h-index 54), centered on Gastrointestinal motility and disorders, Psychosomatic Disorders and Their Treatments, Functional Brain Connectivity Studies. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (2006–2015).

  • Most recent indexed publication: 2020 · Translational psychiatry
  • Top research focus: Gastrointestinal motility and disorders
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
IBS / Functional GI3 trialsDepression (MDD)1 trialMigraine / Headache1 trialPain1 trialWounds and Injuries1 trialHeadache1 trialIBD (Crohn's / UC)

Research focus

OpenAlex concept fingerprint
Gastrointestinal motility and disordersPsychosomatic Disorders and Their TreatmentsFunctional Brain Connectivity StudiesGut microbiota and healthInflammatory Bowel Disease

Drugs & molecules

across trials, industry payments and publications
Givlaarigeneric · GivosiranClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
University of California, Los AngelesClinical trials3Industry payments—Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments1Avera PharmaceuticalsClinical trials1Industry payments—Tsumura USAClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
221publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

11,846citations

Total citations across indexed works.

54h-index

Hirsch index (OpenAlex). i10-index 87.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2025–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2006–2015

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Guanylate Cyclase-C Agonist100%
    Linzess100%
    Part D<11 patients
Where care is delivered (Part B), 20210% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2006–2015 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Emeran A. Mayer170Jennifer S. Labus150Bruce D. Naliboff117Arpana Gupta65Lisa Ann Kilpatrick46Jean Stains42Lin Chang36Cody Ashe-McNalley31Suzanne R. Smith23Brandall Y. Suyenobu20Bahar Ebrat19Jonathan P. Jacobs17Zhiguo Jiang17Joshua A. Bueller15Brennan Mason Ross Spiegel14Jui‐Yang Hong14Eric Esrailian13Lucinda A. Harris13William D. Chey13Anthony J Lembo13Hetal A. Karsan13Susan L. Lucak13Jeffrey M. Lackner13Benjamin M. Ellingson12Ravi R. Bhatt12Claudia P. Sanmiguel12Jennifer Talley11Johanna M. Jarcho11Venu Lagishetty11Kristen Coveleskie11Roger E. Bolus11Carinna M. Torgerson10Maria Engström10Nuwanthi Heendeniya9John D. Van Horn9Kareem Hamadani8Denis Guyonnet8Roger R. Bolus8Wendy Shih7Eduardo Vianna7

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    uclahealth.org/providers/kirsten-tillisch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Member

    Rome IV Committee for Central Disorders of Gastrointestinal Pain

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.